title: Testicular invading refractory multiple myeloma during bortezomib treatment successfully treated with lenalidomide: a case report.
authors.affiliation: Department of Hematology and Oncology, Anjo Kosei Hospital, Higashi-Hirokute 28 Anjo-Chou, Anjo City, Aichi Prefecture, Japan, koutarou380@yahoo.co.jp.
authors.forename: Kotaro
authors.initials: K
authors.lastname: Miyao
authors.forename: Reona
authors.initials: R
authors.lastname: Sakemura
authors.forename: Toshiyasu
authors.initials: T
authors.lastname: Sakai
authors.forename: Natsuko
authors.initials: N
authors.lastname: Tsushita
authors.forename: Tomonori
authors.initials: T
authors.lastname: Kato
authors.forename: Keiko
authors.initials: K
authors.lastname: Niimi
authors.forename: Yoshitaka
authors.initials: Y
authors.lastname: Ono
authors.forename: Masashi
authors.initials: M
authors.lastname: Sawa
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001897:Boronic Acids / Q000627:therapeutic use; D000069286:Bortezomib; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D004317:Doxorubicin / Q000008:administration & dosage / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm; D005834:Genital Neoplasms, Male / Q000188:drug therapy / Q000473:pathology / Q000556:secondary; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000517:prevention & control / Q000601:surgery / Q000628:therapy; D009361:Neoplasm Invasiveness; D009919:Orchiectomy; D061988:Proteasome Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use; D055502:Secondary Prevention; D013085:Spermatic Cord / Q000187:drug effects / Q000473:pathology; D033581:Stem Cell Transplantation; D013736:Testicular Neoplasms / Q000188:drug therapy* / Q000517:prevention & control / Q000556:secondary / Q000601:surgery; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014750:Vincristine / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D001897:Boronic Acids; D061988:Proteasome Inhibitors; D011719:Pyrazines; D013792:Thalidomide; D014750:Vincristine; D000069286:Bortezomib; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide; D000077269:Lenalidomide